Last Updated: May 3, 2026

Senores Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SENORES PHARMS

SENORES PHARMS has fifty-one approved drugs.

Summary for Senores Pharms

US Patents:	0
Tradenames:	47
Ingredients:	47
NDAs:	51

Drugs and US Patents for Senores Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Senores Pharms	METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; metoprolol tartrate	TABLET;ORAL	215789-002	Jan 8, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Senores Pharms	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	OINTMENT;TOPICAL	213619-001	Nov 10, 2020	AT	RX	No	No		⤷ Start Trial				⤷ Start Trial
Senores Pharms	DICLOFENAC POTASSIUM	diclofenac potassium	TABLET;ORAL	215787-001	Mar 15, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Senores Pharms	DEXTROAMPHETAMINE SULFATE	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	076137-003	Jan 18, 2002		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Senores Pharms	RISPERIDONE	risperidone	TABLET, ORALLY DISINTEGRATING;ORAL	077328-002	Oct 5, 2009	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Senores Pharms	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	076033-001	Jan 24, 2002	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Senores Pharms	RAMIPRIL	ramipril	CAPSULE;ORAL	078191-003	Jun 18, 2008	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Senores Pharms

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.